Raaj Medisafe India Limited (BOM:524502)
India · Delayed Price · Currency is INR 99.85
0.00 (0.00%)
At close: Sep 11, 2026
Raaj Medisafe India Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,640 | 931 | 969 | 591 | 255 | 428 | |
Market Cap Growth | 43.36% | -3.87% | 63.82% | 131.52% | -40.28% | 514.43% |
Enterprise Value | 2,157 | 1,445 | 1,249 | 751 | 385 | 511 |
Last Close Price | 99.85 | 70.81 | 73.50 | 54.06 | 23.35 | 39.10 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 74.26 | 51.45 | 15.80 | 17.76 | 7.67 | 14.20 |
PS Ratio | 1.75 | 1.16 | 1.55 | 1.37 | 0.66 | 1.23 |
PB Ratio | 3.51 | 1.99 | 3.60 | 5.46 | 3.41 | 10.31 |
P/TBV Ratio | 3.51 | 1.99 | 3.60 | 5.46 | 3.41 | 10.31 |
P/FCF Ratio | - | - | - | - | - | 34.64 |
P/OCF Ratio | 44.75 | 25.41 | - | 13.83 | 146.79 | 17.49 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 2.30 | 1.81 | 2.00 | 1.74 | 1.00 | 1.47 |
EV/EBITDA Ratio | 16.43 | 12.29 | 14.47 | 11.32 | 6.86 | 10.04 |
EV/EBIT Ratio | 19.72 | 14.87 | 17.38 | 12.95 | 7.93 | 11.70 |
EV/FCF Ratio | - | - | - | - | - | 41.38 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 1.38 | 1.38 | 1.28 | 2.39 | 2.09 | 3.14 |
Debt / EBITDA Ratio | 4.93 | 5.50 | 4.00 | 3.91 | 2.78 | 2.56 |
Debt / FCF Ratio | - | - | - | - | - | 10.54 |
Net Debt / Equity Ratio | 1.11 | 1.11 | 1.28 | 2.39 | 2.08 | 3.13 |
Net Debt / EBITDA Ratio | 3.94 | 4.39 | 4.00 | 3.90 | 2.78 | 2.55 |
Net Debt / FCF Ratio | - | -1.73 | -2.33 | -3.51 | -10.05 | 10.53 |
Asset Turnover | - | 0.84 | 1.13 | 1.29 | 1.70 | 1.92 |
Inventory Turnover | - | 4.47 | 5.27 | 3.92 | 5.54 | 11.13 |
Quick Ratio | - | 0.70 | 0.61 | 0.56 | 0.67 | 0.63 |
Current Ratio | - | 1.43 | 1.07 | 1.16 | 1.34 | 1.05 |
Return on Equity (ROE) | - | 4.91% | 32.48% | 36.32% | 57.21% | 115.41% |
Return on Assets (ROA) | - | 6.39% | 8.14% | 10.81% | 13.39% | 15.07% |
Return on Invested Capital (ROIC) | 3.44% | 3.48% | 14.64% | 15.05% | 21.33% | 22.53% |
Return on Capital Employed (ROCE) | - | 11.30% | 17.40% | 22.80% | 33.60% | 43.20% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 1.42% | 1.94% | 6.33% | 5.63% | 13.04% | 7.04% |
FCF Yield | -18.19% | -32.04% | -15.28% | -12.45% | -6.08% | 2.89% |
Buyback Yield / Dilution | -29.60% | -24.63% | -20.87% | - | -2.06% | 3.82% |